JP Morgan Chase
ASPX

JP Morgan Chase’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

JP Morgan Chase’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-450,734
Closed -$45.2M – 4359
2015
Q1 		$45.2M Buy
450,734
+165,359
+58% +$11M 0.01% 950
2014
Q4 		$15M Sell
285,375
-29,232
-9% -$858K ﹤0.01% 1664
2014
Q3 		$8.08M Sell
314,607
-1,525
-0.5% -$32.4K ﹤0.01% 2065
2014
Q2 		$7.04M Buy
316,132
+239,057
+310% +$5.23M ﹤0.01% 1916
2014
Q1 		$2.37M Buy
+77,075
New +$2.07M ﹤0.01% 2465

JP Morgan Chase's ASPX Position: Q2 2015 in Review

JP Morgan Chase sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 450,734 shares — an estimated $45.2M sold.

JP Morgan Chase first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $45.2M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • JP Morgan Chase reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • JP Morgan Chase sold 450,734 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $45.2M.
  • JP Morgan Chase first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • JP Morgan Chase's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $45.2M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.